Genetic variants associated with susceptibility to psychosis in late-onset Alzheimer’s disease families

Psychotic symptoms are frequent in late-onset Alzheimer's disease (LOAD) patients. Although the risk for psychosis in LOAD is genetically mediated, no genes have been identified. To identify loci potentially containing genetic variants associated with risk of psychosis in LOAD, a total of 263 families from the National Institute of Aging-LOAD cohort were classified into psychotic (LOAD+P, n = 215) and nonpsychotic (LOAD-P, n = 48) families based on the presence/absence of psychosis during the course of LOAD. The LOAD+P families yielded strong evidence of linkage on chromosome 19q13 (two-point [2-pt] ​logarithm of odds [LOD] = 3.8, rs2285513 and multipoint LOD = 2.7, rs541169). Joint linkage and association in 19q13 region detected strong association with rs2945988 (p = 8.7 × 10(-7)). Linkage results for the LOAD-P families yielded nonsignificant 19q13 LOD scores. Several 19q13 single-nucleotide polymorphisms generalized the association of LOAD+P in a Caribbean Hispanic (CH) cohort, and the strongest signal was rs10410711 (pmeta = 5.1 × 10(-5)). A variant located 24 kb upstream of rs10410711 and rs10421862 was strongly associated with LOAD+P (pmeta = 1.0 × 10(-5)) in a meta-analysis of the CH cohort and an additional non-Hispanic Caucasian dataset. Identified variants rs2945988 and rs10421862 affect brain gene expression levels. Our results suggest that genetic variants in genes on 19q13, some of which are involved in brain development and neurodegeneration, may influence the susceptibility to psychosis in LOAD patients.

[1]  M. Folstein,et al.  Clinical diagnosis of Alzheimer's disease , 1984, Neurology.

[2]  M. Hamshere,et al.  Increased familial risk and genomewide significant linkage for Alzheimer's disease with psychosis , 2007, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.

[3]  B. Devlin,et al.  Linkage analysis of Alzheimer disease with psychosis , 2002, Neurology.

[4]  B. Devlin,et al.  Neuregulin‐1 polymorphism in late onset Alzheimer's disease families with psychoses , 2005, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.

[5]  W. Thies,et al.  2013 Alzheimer's disease facts and figures , 2013, Alzheimer's & Dementia.

[6]  Yaakov Stern,et al.  Memory performance in healthy elderly without Alzheimer’s disease: effects of time and apolipoprotein-E , 2001, Neurobiology of Aging.

[7]  M. Folstein,et al.  Clinical diagnosis of Alzheimer's disease: Report of the NINCDS—ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease , 2011, Neurology.

[8]  O. Lopez,et al.  Psychosis in Alzheimer's Disease in the National Alzheimer's Disease Coordinating Center Uniform Data Set: Clinical Correlates and Association with Apolipoprotein E , 2011, International journal of Alzheimer's disease.

[9]  J. Pettegrew,et al.  Psychosis in Alzheimer disease: postmortem magnetic resonance spectroscopy evidence of excess neuronal and membrane phospholipid pathology , 2002, Neurobiology of Aging.

[10]  G. Abecasis,et al.  Merlin—rapid analysis of dense genetic maps using sparse gene flow trees , 2002, Nature Genetics.

[11]  C. Ha,et al.  SNX26, a GTPase-activating Protein for Cdc42, Interacts with PSD-95 Protein and Is Involved in Activity-dependent Dendritic Spine Formation in Mature Neurons* , 2013, The Journal of Biological Chemistry.

[12]  C. Spencer,et al.  Biological Insights From 108 Schizophrenia-Associated Genetic Loci , 2014, Nature.

[13]  S. Wisniewski,et al.  Psychotic Symptoms in Alzheimer's Disease Are Not Associated With More Severe Neuropathologic Features , 2000, International Psychogeriatrics.

[14]  R A Ophoff,et al.  Expanding the range of ZNF804A variants conferring risk of psychosis , 2011, Molecular Psychiatry.

[15]  R. Sweet,et al.  Genetics of psychosis in Alzheimer's disease: a review. , 2010, Journal of Alzheimer's disease : JAD.

[16]  N. Morton,et al.  The detection and estimation of linkage between the genes for elliptocytosis and the Rh blood type. , 1956, American journal of human genetics.

[17]  Alejandro A. Schäffer,et al.  PSEUDOMARKER 2.0: efficient computation of likelihoods using NOMAD , 2014, BMC Bioinformatics.

[18]  J. Cummings,et al.  Validation of the NPI-Q, a brief clinical form of the Neuropsychiatric Inventory. , 2000, The Journal of neuropsychiatry and clinical neurosciences.

[19]  B. Devlin,et al.  Heritability of psychosis in Alzheimer disease. , 2005, The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry.

[20]  S. Wisniewski,et al.  Psychiatric medication and abnormal behavior as predictors of progression in probable Alzheimer disease. , 1999, Archives of neurology.

[21]  James T Becker,et al.  Effect of Alzheimer's disease risk genes on trajectories of cognitive function in the Cardiovascular Health Study. , 2012, The American journal of psychiatry.

[22]  Joseph A. Gogos,et al.  Strong association of de novo copy number mutations with sporadic schizophrenia , 2008, Nature Genetics.

[23]  Raul Urrutia,et al.  KRAB-containing zinc-finger repressor proteins , 2003, Genome Biology.

[24]  E. Tangalos,et al.  Mild Cognitive Impairment Clinical Characterization and Outcome , 1999 .

[25]  O L Lopez,et al.  Genome-wide copy-number variation study of psychosis in Alzheimer's disease , 2015, Translational Psychiatry.

[26]  D. Schaid,et al.  Age-specific incidence rates for dementia and Alzheimer disease in NIA-LOAD/NCRAD and EFIGA families: National Institute on Aging Genetics Initiative for Late-Onset Alzheimer Disease/National Cell Repository for Alzheimer Disease (NIA-LOAD/NCRAD) and Estudio Familiar de Influencia Genetica en Alzhei , 2014, JAMA neurology.

[27]  R. Wilson,et al.  Hallucinations, Cognitive Decline, and Death in Alzheimer’s Disease , 2006, Neuroepidemiology.

[28]  E. Lander,et al.  Genetic dissection of complex traits: guidelines for interpreting and reporting linkage results , 1995, Nature Genetics.

[29]  J. Ott Computer-simulation methods in human linkage analysis. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[30]  Brian Lawlor,et al.  Genome-wide Association Study of Alzheimer’s disease with Psychotic Symptoms , 2011, Molecular Psychiatry.

[31]  C. Lyketsos,et al.  Delusions and hallucinations in Alzheimer's disease: prevalence and clinical correlates , 2000, International journal of geriatric psychiatry.

[32]  E. Wijsman,et al.  Genome-Wide Association of Familial Late-Onset Alzheimer's Disease Replicates BIN1 and CLU and Nominates CUGBP2 in Interaction with APOE , 2011, PLoS genetics.

[33]  M. Albert,et al.  Delusions and hallucinations are associated with worse outcome in Alzheimer disease. , 2005, Archives of neurology.

[34]  C. Woods,et al.  WDR62 is associated with the spindle pole and is mutated in human microcephaly , 2010, Nature Genetics.

[35]  D. Bennett,et al.  Assessment and familial aggregation of psychosis in Alzheimer's disease from the National Institute on Aging Late Onset Alzheimer's Disease Family Study. , 2010, Brain : a journal of neurology.

[36]  S. Bassett,et al.  Linkage to chromosome 14q in Alzheimer's disease (AD) patients without psychotic symptoms , 2005, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.

[37]  A. Morris,et al.  Transethnic Meta-Analysis of Genomewide Association Studies , 2011, Genetic epidemiology.

[38]  J. L. Mack,et al.  Behavior Rating Scale for Dementia: Development of Test Scales and Presentation of Data for 555 Individuals with Alzheimer's Disease , 1999, Journal of geriatric psychiatry and neurology.

[39]  J. Manson,et al.  Generalization of adiposity genetic loci to US Hispanic women , 2013, Nutrition & Diabetes.